Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
Matthieu Jestin(Sorbonne Université), Paul Coppo(Sorbonne Université), Christiane Mousson(Metabolism and Renal Physiology), Lionel Galicier(Hôpital de la Timone), P. Cathébras(Hôpital Cochin), Anne Charvet‐Rumpler(Sorbonne Université), Claire Presne(Sorbonne Université), An‐Sofie Schelpe(Research Institute for Chromatography), Samir Saheb(Sorbonne Université), Tarik Kanouni(Sorbonne Université), Agnès Veyradier(Inserm), Aude Servais(Hôpital Necker-Enfants Malades), Y. Benhamou(Inserm), Yahsou Delmas(Centre Hospitalier Universitaire de Bordeaux), M. Hamidou(Centre Hospitalier Universitaire de Nantes), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Stéphane Girault(Centre Hospitalier Universitaire de Limoges), Pierre Perez, François Provôt(Centre Oscar Lambret), Pascale Poullin(Centre National de la Recherche Scientifique), Dominique Chauveau(Hôpital Rangueil), Alexandre Lautrette(Centre Hospitalier Universitaire de Clermont-Ferrand), Alain Wynckel(Centre Hospitalier Universitaire de Reims), Elien Roose(Research Institute for Chromatography), C. Deligny(Centre Hospitalier Universitaire de Martinique), Karen Vanhoorelbeke(Research Institute for Chromatography)
Cited by 163
Related Papers
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316